NeuroOne Medical Technologies
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Frequently asked questions
To buy NeuroOne Medical Technologies stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NeuroOne Medical Technologies by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NeuroOne Medical Technologies is NMTC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NeuroOne Medical Technologies has its primary listing on NASDAQ (Small cap). You can trade NeuroOne Medical Technologies with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NeuroOne Medical Technologies is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include NeuroOne Medical Technologies as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like NeuroOne Medical Technologies .